Skip to Content

Aspen Pharmacare Holdings Ltd ADR APNHY Stock Quote

| Rating as of


Morningstar‘s Stock Analysis APNHY

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics APNHY

Company Profile APNHY

Business Description

Aspen Pharmacare Holdings Ltd is a South African-based global specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The group's commercial pharmaceuticals business comprises Sterile Focus and Regional Brands. Aspen has invested in strategically relevant manufacturing capacity and has capabilities across biological and chemical APIs, orals, liquids, topicals and steriles, at 23 manufacturing facilities on 6 continents.

Douglas Saunders Drive, Aspen Place
Durban, NL, South Africa
T +27 315808600
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Fiscal Year End Jun 30, 2023
Employees 9,167